Dr. Jeffrey Fraser, DO
What this data tells you about Dr. Fraser
Dr. Jeffrey Fraser is a family medicine specialist in Venice, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fraser performed 11,053 Medicare services across 6,730 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fraser received a total of $3,739 from 31 pharmaceutical and/or device companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fraser is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 8974 | Clear | March 31, 2028 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,581 | $18 | $47 |
| Office visit, established patient (30-39 min) | 1,428 | $88 | $264 |
| Blood draw (venipuncture) | 772 | $8 | $17 |
| Comprehensive metabolic blood panel | 636 | $10 | $21 |
| Complete blood count (CBC) with differential | 572 | $8 | $16 |
| Annual wellness visit, follow-up | 568 | $128 | $267 |
| Lipid panel (cholesterol and triglycerides) | 536 | $13 | $27 |
| Thyroid stimulating hormone (TSH) test | 510 | $16 | $34 |
| Hemoglobin A1c test (diabetes monitoring) | 478 | $10 | $19 |
| Annual depression screening | 373 | $18 | $38 |
| Office visit, established patient (20-29 min) | 188 | $57 | $187 |
| Free thyroxine (T4) test | 184 | $9 | $18 |
| Flu vaccine administration | 178 | $30 | $64 |
| Flu vaccine, high-dose | 175 | $72 | $144 |
| Vitamin D level test | 158 | $29 | $59 |
| Pneumonia vaccine administration | 144 | $30 | $64 |
| Vitamin B-12 level test | 132 | $15 | $30 |
| Pneumococcal vaccine, 23-valent | 126 | $131 | $267 |
| Prothrombin time test (blood clotting) | 96 | $4 | $9 |
| Urine microalbumin test (kidney screening) | 92 | $6 | $12 |
| Creatinine test (kidney function) | 92 | $5 | $10 |
| Prostate cancer screening; prostate specific antigen test (psa) | 90 | $19 | $39 |
| Urinalysis, manual | 74 | $3 | $7 |
| PSA test (prostate cancer screening) | 69 | $18 | $37 |
| Transitional care management services for problem of high complexity | 61 | $215 | $570 |
| Drug injection, under skin or into muscle | 60 | $9 | $30 |
| Uric acid level test | 55 | $4 | $9 |
| Electrocardiogram (EKG), 12-lead | 51 | $11 | $30 |
| Urine culture, bacterial colony count | 46 | $8 | $16 |
| Ferritin level test (iron stores) | 39 | $13 | $27 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 38 | $40 | $107 |
| Iron level test | 37 | $6 | $13 |
| Iron binding capacity test | 37 | $9 | $17 |
| Glutamyltransferase (liver enzyme) level | 34 | $7 | $14 |
| C-reactive protein test (inflammation marker) | 30 | $5 | $10 |
| Natriuretic peptide (heart and blood vessel protein) level | 29 | $38 | $79 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 28 | $30 | $86 |
| Sed rate test (inflammation marker) | 25 | $3 | $5 |
| Transitional care management services for problem of at least moderate complexity | 23 | $157 | $420 |
| New patient office visit (45-59 min) | 20 | $119 | $347 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $267 | $577 |
| Amylase (enzyme) level | 17 | $6 | $13 |
| Lipase (fat enzyme) level | 17 | $7 | $14 |
| Bacterial culture, aerobic | 17 | $8 | $16 |
| Antibiotic sensitivity test | 17 | $8 | $17 |
| Urinalysis with microscopic exam | 16 | $3 | $6 |
| Folic acid level test | 16 | $14 | $29 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 16 | $166 | $343 |
| Automated urinalysis | 14 | $2 | $4 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 14 | $9 | $30 |
| Testing for presence of drug, read by direct observation | 13 | $12 | $25 |
| New patient office visit (30-44 min) | 13 | $76 | $235 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fraser is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), with low-engagement industry engagement in the top 14% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fraser experienced with denosumab injection (prolia/xgeva)?
Does Dr. Fraser receive payments from pharmaceutical companies?
How do Dr. Fraser's costs compare to other family medicine physicians in Venice?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology